Find News

Filter articles

Applied Filters

Showing 81 to 90 of 700 results

NHS to receive £8m from Aspen over anti-competitive practices

UK15-08-2019Sarah Morgan

Drugmaker Aspen has offered to pay the UK’s National Health System £8 million to resolve competition concerns.

Jazz Pharma buys clinical-stage biotech company

Ireland14-08-2019Sarah Morgan

Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million.

Bayer buys BlueRock to build cell therapy expertise

Germany, US09-08-2019Sarah Morgan

Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.

EU requests WTO panel over Turkey’s pharma measures

EU05-08-2019Sarah Morgan

The European Union has asked the World Trade Organization to establish a panel on Turkey’s measures on pharmaceutical products.

Vaccines growth offsets Advair generic pain for GSK

UK25-07-2019Sarah Morgan

Growth in GlaxoSmithKline’s vaccines and consumer healthcare divisions has managed to partly counter the impact of generic versions of Advair on its sales.

EU invests €35m into AI cancer diagnostics

EU10-07-2019Sarah Morgan

The European Commission has pledged €35 million to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence.

EMA settles Brexit dispute; issues drug shortages guidance

EU08-07-2019Sarah Morgan

The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

UKIPO seeks no-deal Brexit SPC comments

EU, UK05-07-2019

The UK Intellectual Property Office has today, July 5, opened a consultation into supplementary protection certificate law in the event of a ‘no deal’ Brexit.

CJEU rejects Viridis TM plea over MS drug


The Court of Justice of the European Union has rejected a trademark appeal submitted by Virgin Islands-headquartered Viridis Pharmaceutical.

Cancer Research UK partners with VC firm in $25m deal


Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.

Showing 81 to 90 of 700 results